Detection of PD-L1 expression on HNSCC cells

The Programmed Death (PD) pathway, involving receptor PD-1 on T-cells and ligand PD-L1 on tumor cells is an important immunotherapeutic checkpoint to inhibit in the control of head and neck squamous cell carcinoma (HNSCC).